Clinical application of C-reactive protein for cardiovascular disease detection and prevention

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850 · see citing works

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504 · see citing works

C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus

Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433 · see citing works

Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events

Ridker, P. M., Rifai, N., Rose, L., Buring, J. E., & Cook, N. R. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021993 · Cited by 3,604 · see citing works

The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina

Liuzzo, G., Biasucci, L. M., Gallimore, J. R., Grillo, R. L., Rebuzzi, A. G., Pepys, M. B., & Maseri, A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408183310701 · Cited by 2,354 · see citing works

C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events: An 8-Year Follow-Up of 14 719 Initially Healthy American Women

Ridker, P. M., Buring, J. E., Cook, N. R., & Rifai, N. (2003) · Circulation · doi:10.1161/01.cir.0000055014.62083.05 · Cited by 2,292 · see citing works

C-Reactive Protein, a Sensitive Marker of Inflammation, Predicts Future Risk of Coronary Heart Disease in Initially Healthy Middle-Aged Men

Köenig, W., Sund, M., Fröhlich, M., Fischer, H.-G., Löwel, H., Döring, A., Hutchinson, W. L., & Pepys, M. B. (1999) · Circulation · doi:10.1161/01.cir.99.2.237 · Cited by 1,952 · see citing works

Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses

Danesh, J. (2000) · BMJ · doi:10.1136/bmj.321.7255.199 · Cited by 1,692 · see citing works

Effect of Statin Therapy on C-Reactive Protein Levels

Albert, M. A., Danielson, E., Rifai, N., Ridker, P. M., & for the PRINCE Investigators (2001) · JAMA · doi:10.1001/jama.286.1.64 · Cited by 1,642 · see citing works

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events

Ridker, P. M., Rifai, N., Clearfield, M., Downs, J. R., Weis, S. E., Miles, J. S., & Gotto, A. M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106283442601 · Cited by 1,557 · see citing works

Production of C-reactive protein and risk of coronary events in stable and unstable angina

Haverkate, E., Thompson, S. G., Pyke, S., Gallimore, J. R., & Mark B Pepys Group (1997) · The Lancet · doi:10.1016/s0140-6736(96)07591-5 · Cited by 1,511 · see citing works

Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly

Harris, T. B., Ferrucci, L., Tracy, R. P., Corti, M. C., Wacholder, S., Ettinger, W. H., Heimovitz, H., Cohen, H. J., & Wallace, R. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00066-2 · Cited by 1,488 · see citing works

Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive Protein

Ridker, P. M., Rifai, N., Pfeffer, M. A., Sacks, F. M., & D, E. B. M. (1999) · Circulation · doi:10.1161/01.cir.100.3.230 · Cited by 1,479 · see citing works

High-Sensitivity C-Reactive Protein: Potential Adjunct for Global Risk Assessment in the Primary Prevention of Cardiovascular Disease

Ridker, P. M. (2001) · Circulation · doi:10.1161/01.cir.103.13.1813 · Cited by 1,402 · see citing works

Inflammation, Pravastatin, and the Risk of Coronary Events After Myocardial Infarction in Patients With Average Cholesterol Levels

Ridker, P. M., Rifai, N., Pfeffer, M. A., Sacks, F. M., Moye, L. A., Goldman, S., Flaker, G. C., & Braunwald, E. (1998) · Circulation · doi:10.1161/01.cir.98.9.839 · Cited by 1,389 · see citing works

Novel Risk Factors for Systemic Atherosclerosis

Ridker, P. M., Stampfer, M. J., & Rifai, N. (2001) · JAMA · doi:10.1001/jama.285.19.2481 · Cited by 1,300 · see citing works

Markers of Myocardial Damage and Inflammation in Relation to Long-Term Mortality in Unstable Coronary Artery Disease

Lindahl, B., Toss, H., Siegbahn, A., Venge, P., & Wallentin, L. C. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010193431602 · Cited by 1,221 · see citing works

Relation of C-Reactive Protein and Coronary Heart Disease in the MRFIT Nested Case-Control Study

Kuller, L. H., Tracy, R. P., Shaten, J., & Meilahn, E. N. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008963 · Cited by 1,098 · see citing works

C-Reactive Protein Adds to the Predictive Value of Total and HDL Cholesterol in Determining Risk of First Myocardial Infarction

Ridker, P. M., Glynn, R. J., & Hennekens, C. H. (1998) · Circulation · doi:10.1161/01.cir.97.20.2007 · Cited by 1,012 · see citing works

Effect of Rosiglitazone Treatment on Nontraditional Markers of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus

Haffner, S. M., Greenberg, A. S., Weston, W. M., Chen, H., Williams, K., & Freed, M. I. (2002) · Circulation · doi:10.1161/01.cir.0000025403.20953.23 · Cited by 882 · see citing works

Relationship of C-Reactive Protein to Risk of Cardiovascular Disease in the Elderly: Results From the Cardiovascular Health Study and the Rural Health Promotion Project

Tracy, R. P., Lemaitre, R. N., Psaty, B. M., Ives, D. G., Evans, R. W., Cushman, M., Meilahn, E. N., & Kuller, L. H. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.6.1121 · Cited by 836 · see citing works

C-Reactive Protein Is a Potent Predictor of Mortality Independently of and in Combination With Troponin T in Acute Coronary Syndromes: A TIMI 11A Substudy

Morrow, D. A., Rifai, N., Antman, E. M., Weiner, D. L., McCabe, C. H., Cannon, C. P., & D, E. B. M. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00136-3 · Cited by 780 · see citing works

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events

Ridker, P. M., Rifai, N., & Clearfield, M. B. (2001) · ACC Current Journal Review · doi:10.1016/s1062-1458(01)00460-3 · Cited by 762 · see citing works

Novel Clinical Markers of Vascular Wall Inflammation

Blake, G. J., & Ridker, P. M. (2001) · Circulation Research · doi:10.1161/hh2101.099270 · Cited by 754 · see citing works

C-Reactive Protein Is an Independent Predictor of Risk for the Development of Diabetes in the West of Scotland Coronary Prevention Study

Freeman, D. J., Norrie, J. D., CASLAKE, M. J., Gaw, A., Ford, I., Lowe, G. D. O., O’Reilly, D. S. J., Packard, C. J., Sattar, N. A., & for the West of Scotland Coronary Prevention Study Group (2002) · Diabetes · doi:10.2337/diabetes.51.5.1596 · Cited by 720 · see citing works

Inflammatory Biomarkers, Hormone Replacement Therapy, and Incident Coronary Heart Disease

Pradhan, A. D., Manson, J. E., Rossouw, J. E., Siscovick, D. S., Mouton, C. P., Rifai, N., Wallace, R. B., Jackson, R. D., Pettinger, M. B., & Ridker, P. M. (2002) · JAMA · doi:10.1001/jama.288.8.980 · Cited by 680 · see citing works

Effect of Postmenopausal Hormones on Inflammation-Sensitive Proteins: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Study

Cushman, M., Legault, C., Barrett-Connor, E., Stefanick, M. L., Kessler, C., Judd, H. L., Sakkinen, P. A., & Tracy, R. P. (1999) · Circulation · doi:10.1161/01.cir.100.7.717 · Cited by 660 · see citing works

Evaluation of Nine Automated High-Sensitivity C-Reactive Protein Methods: Implications for Clinical and Epidemiological Applications. Part 2

Roberts, W. L., Moulton, L., Law, T. C., Farrow, G., Cooper-Anderson, M., Savory, J., & Rifai, N. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.3.418 · Cited by 652 · see citing works

Relationship Between Interleukin 6 and Mortality in Patients With Unstable Coronary Artery Disease

Lindmark, E., Diderholm, E., Wallentin, L. C., & Siegbahn, A. (2001) · JAMA · doi:10.1001/jama.286.17.2107 · Cited by 557 · see citing works

Prospective Study of C-Reactive Protein, Homocysteine, and Plasma Lipid Levels as Predictors of Sudden Cardiac Death

Albert, C. M., Ma, J., Rifai, N., Stampfer, M. J., & Ridker, P. M. (2002) · Circulation · doi:10.1161/01.cir.0000017493.03108.1c · Cited by 532 · see citing works

Hormone Replacement Therapy and Increased Plasma Concentration of C-Reactive Protein

Ridker, P. M., Hennekens, C. H., Rifai, N., Buring, J. E., & Manson, J. E. (1999) · Circulation · doi:10.1161/01.cir.100.7.713 · Cited by 442 · see citing works

Variability and Classification Accuracy of Serial High-Sensitivity C-Reactive Protein Measurements in Healthy Adults

Ockene, I. S., Matthews, C. E., Rifai, N., Ridker, P. M., Reed, G. W., & Stanek, E. J. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.3.444 · Cited by 411 · see citing works

Low-Density Lipoprotein Particle Concentration and Size as Determined by Nuclear Magnetic Resonance Spectroscopy as Predictors of Cardiovascular Disease in Women

Blake, G. J., Otvos, J. D., Rifai, N., & Ridker, P. M. (2002) · Circulation · doi:10.1161/01.cir.0000033222.75187.b9 · Cited by 409 · see citing works

Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events

Ridker, P. M., Rifai, N., Rose, L. M., Buring, J. E., & Cook, N. R. (2003) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000058687.18516.14 · Cited by 390 · see citing works

C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men

Mendall, M. A. (2000) · European Heart Journal · doi:10.1053/euhj.1999.1982 · Cited by 359 · see citing works

Inflammation and Long-Term Mortality After Non–ST Elevation Acute Coronary Syndrome Treated With a Very Early Invasive Strategy in 1042 Consecutive Patients

Mueller, C. E., Buettner, H. J., Hodgson, J. M., Marsch, S. C. U., Perruchoud, A. P., Roskamm, H., & Neumann, F. (2002) · Circulation · doi:10.1161/01.cir.0000012625.02748.62 · Cited by 248 · see citing works

Abciximab Suppresses the Rise in Levels of Circulating Inflammatory Markers After Percutaneous Coronary Revascularization

Lincoff, A. M., Kereiakes, D. J., Mascelli, M. A., Deckelbaum, L. I., Barnathan, E. S., Patel, K. K., Frederick, B., Nakada, M. T., & Topol, E. J. (2001) · Circulation · doi:10.1161/01.cir.104.2.163 · Cited by 196 · see citing works

C-reactive protein and myocardial infarction

Sakkinen, P. A., Abbott, R. D., Curb, J. D., Rodríguez, B. L., Yano, K., & Tracy, R. P. (2002) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(01)00502-9 · Cited by 178 · see citing works

Need to Test the Arterial Inflammation Hypothesis

Bhatt, D. L., & Topol, E. J. (2002) · Circulation · doi:10.1161/01.cir.0000021112.29409.a2 · Cited by 136 · see citing works

Effect of Clopidogrel added to aspirin before percutaneous coronary intervention on the risk associated with C-reactive protein

Chew, D. P., Bhatt, D. L., Robbins, M. A., Mukherjee, D., Roffi, M., Schneider, J. P., Topol, E. J., & Ellis, S. G. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01813-6 · Cited by 135 · see citing works

Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease. Prospective analysis from the women’s health initiative observational study

Pradhan, A. D., Manson, J. E., & Rossouw, J. E. (2003) · ACC Current Journal Review · doi:10.1016/s1062-1458(02)01008-5 · Cited by 94 · see citing works

Is C-Reactive Protein Specific for Vascular Disease in Women?

Rifai, N., Buring, J. E., Lee, I.-M. M., Manson, J. E., & Ridker, P. M. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-7-200204020-00010 · Cited by 78 · see citing works

Should statin therapy be considered for patients with elevated C-reactive protein? The need for a definitive clinical trial

Ridker, P. M. (2001) · European Heart Journal · doi:10.1053/euhj.2001.2990 · Cited by 54 · see citing works

Projected life-expectancy gains with statin therapy for individuals with elevated c-reactive protein levels

Blake, G. J., Ridker, P. M., & Kuntz, K. M. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01914-9 · Cited by 39 · see citing works

Role of C-Reactive Protein at Sites of Inflammation and Infection

Sproston, N. R., & Ashworth, J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00754 · Cited by 3,053 · see citing works

The Metabolic Syndrome: Time for a Critical Appraisal

Kahn, R., Buse, J. B., Ferrannini, E., & Stern, M. P. (2005) · Diabetes Care · doi:10.2337/diacare.28.9.2289 · Cited by 2,377 · see citing works

Adipose Tissue, Inflammation, and Cardiovascular Disease

Berg, A. H., & Scherer, P. E. (2005) · Circulation Research · doi:10.1161/01.res.0000163635.62927.34 · Cited by 2,113 · see citing works

Recent advances in the relationship between obesity, inflammation, and insulin resistance.

Bastard, J., Maachi, M., Lagathu, C., Kim, M. J., Caron, M., Vidal, H., Capeau, J., & Fève, B. (2006) · PubMed · Cited by 2,069 · see citing works

Serum Procalcitonin and C-Reactive Protein Levels as Markers of Bacterial Infection: A Systematic Review and Meta-analysis

Simon, L., Gauvin, F., Amre, D. K., Saint-Louis, P., & Lacroix, J. (2004) · Clinical Infectious Diseases · doi:10.1086/421997 · Cited by 1,779 · see citing works

Psychological stress in childhood and susceptibility to the chronic diseases of aging: Moving toward a model of behavioral and biological mechanisms.

Miller, G. E., Chen, E., & Parker, K. J. (2011) · Psychological Bulletin · doi:10.1037/a0024768 · Cited by 1,785 · see citing works

Obesity, Metabolic Syndrome, and Cardiovascular Disease

Grundy, S. M. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0372 · Cited by 1,369 · see citing works

Statin Therapy, LDL Cholesterol, C-Reactive Protein, and Coronary Artery Disease

Nissen, S. E., Tuzcu, E. M., Schoenhagen, P., Crowe, T., Sasiela, W. J., Tsai, J., Orazem, J., Magorien, R. D., O'Shaughnessy, C., & Ganz, P. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042000 · Cited by 1,325 · see citing works

Inflammation as a Cardiovascular Risk Factor

Willerson, J. T., & Ridker, P. M. (2004) · Circulation · doi:10.1161/01.cir.0000129535.04194.38 · Cited by 1,304 · see citing works

Mortality in COPD: role of comorbidities

Sin, D. D., Anthonisen, N. R., Soriano, J. B., & Agusti, A. G. (2006) · European Respiratory Journal · doi:10.1183/09031936.00133805 · Cited by 1,052 · see citing works

The vagus nerve and the inflammatory reflex – linking immunity and metabolism

Pavlov, V. A., & Tracey, K. J. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.189 · Cited by 1,040 · see citing works

Periodontal Disease and Atherosclerotic Vascular Disease: Does the Evidence Support an Independent Association?: A Scientific Statement From the American Heart Association

Lockhart, P. B., Bolger, A. F., Papapanou, P. N., Osinbowale, O., Trevisan, M., Levison, M. E., Taubert, K. A., Newburger, J. W., Gornik, H. L., Gewitz, M. H., et al. (2012) · Circulation · doi:10.1161/cir.0b013e31825719f3 · Cited by 1,038 · see citing works

Myeloperoxidase Serum Levels Predict Risk in Patients With Acute Coronary Syndromes

Baldus, S. E., Heeschen, C., Meinertz, T., Zeiher, A. M., Eiserich, J. P., Münzel, T. F., Simoons, M. L., & Hamm, C. W. (2003) · Circulation · doi:10.1161/01.cir.0000090690.67322.51 · Cited by 1,007 · see citing works

Psychoneuroimmunology Meets Neuropsychopharmacology: Translational Implications of the Impact of Inflammation on Behavior

Haroon, E., Raison, C. L., & Miller, A. H. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.205 · Cited by 1,000 · see citing works

Adipokines: molecular links between obesity and atheroslcerosis

Lau, D., Dhillon, B., Yan, H., Szmitko, P. E., & Verma, S. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01058.2004 · Cited by 930 · see citing works

Inflammation in Atherosclerosis: From Vascular Biology to Biomarker Discovery and Risk Prediction

Packard, R. R. S., & Libby, P. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.097360 · Cited by 925 · see citing works

Genetically elevated C-reactive protein and ischemic vascular disease

Zacho, J., Tybjærg-Hansen, A., Jensen, J. S., Grande, P., Sillesen, H., & Nordestgaard, B. G. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707402 · Cited by 839 · see citing works

Biological markers of oxidative stress: Applications to cardiovascular research and practice

Ho, E. C., Galougahi, K. K., Liu, C., Bhindi, R., & Figtree, G. A. (2013) · Redox Biology · doi:10.1016/j.redox.2013.07.006 · Cited by 812 · see citing works

Inflammatory Markers and Risk of Developing Type 2 Diabetes in Women

Hu, F. B., Meigs, J. B., Li, T. Y., Rifai, N., & Manson, J. E. (2004) · Diabetes · doi:10.2337/diabetes.53.3.693 · Cited by 788 · see citing works

Prevalence of low-grade inflammation in depression: a systematic review and meta-analysis of CRP levels

Osimo, E. F., Baxter, L. J., Lewis, G., Jones, P. B., & Khandaker, G. M. (2019) · Psychological Medicine · doi:10.1017/s0033291719001454 · Cited by 774 · see citing works

Race and Gender Differences in C-Reactive Protein Levels

Khera, A., McGuire, D. K., Murphy, S. A., Stanek, H. G., Das, S. R., Vongpatanasin, W., Wians, F. H., Grundy, S. M., & de Lemos, J. A. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.04.051 · Cited by 773 · see citing works

National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 1—Full Report

Jacobson, T. A., Ito, M. K., Maki, K. C., Orringer, C. E., Bays, H. E., Jones, P. H., McKenney, J. M., Grundy, S. M., Gill, E. A., Wild, R. A., et al. (2015) · Journal of clinical lipidology · doi:10.1016/j.jacl.2015.02.003 · Cited by 772 · see citing works

The role of TNF-α in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk

Popa, C. D., Netea, M. G., van Riel, P. L. C. M., van der Meer, J. W. M., & Stalenhoef, A. F. H. (2007) · Journal of Lipid Research · doi:10.1194/jlr.r600021-jlr200 · Cited by 765 · see citing works

New Markers of Inflammation and Endothelial Cell Activation: Part I

Szmitko, P. E., Wang, C.-H., Weisel, R. D., de Almeida, J. R., Anderson, T. J., & Verma, S. (2003) · Circulation · doi:10.1161/01.cir.0000089190.95415.9f · Cited by 738 · see citing works

Adipokines: The missing link between insulin resistance and obesity

Antuna-Puente, B., Fève, B., Fellahi, S., & Bastard, J. (2008) · Diabetes & Metabolism · doi:10.1016/j.diabet.2007.09.004 · Cited by 738 · see citing works

Acute-phase proteins: As diagnostic tool

Jain, S., Gautam, V., & Naseem, S. (2011) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/0975-7406.76489 · Cited by 656 · see citing works

Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development

Mayers, J. R., Wu, C. H., Clish, C. B., Kraft, P., Torrence, M. E., Fiske, B. P., Yuan, C., Bao, Y., Townsend, M. K., Tworoger, S. S., et al. (2014) · Nature Medicine · doi:10.1038/nm.3686 · Cited by 652 · see citing works

Should C-Reactive Protein Be Added to Metabolic Syndrome and to Assessment of Global Cardiovascular Risk?

Ridker, P. M., Wilson, P. W. F., & Grundy, S. M. (2004) · Circulation · doi:10.1161/01.cir.0000132467.45278.59 · Cited by 645 · see citing works

Leukocyte count and coronary heart disease

Madjid, M., Awan, I., Willerson, J. T., & Casscells, S. W. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.07.056 · Cited by 645 · see citing works

C-reactive protein: Ligands, receptors and role in inflammation

Marnell, L. L., Mold, C., & Clos, T. W. D. (2005) · Clinical Immunology · doi:10.1016/j.clim.2005.08.004 · Cited by 625 · see citing works

Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression

Felger, J. C., Li, Z., Haroon, E., Woolwine, B. J., Jung, M. Y., Hu, X., & Miller, A. H. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.168 · Cited by 620 · see citing works

Neuroendocrine-Immune Mechanisms of Behavioral Comorbidities in Patients With Cancer

Miller, A. H., Ancoli‐Israel, S., Bower, J. E., Capuron, L., & Irwin, M. R. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.10.7805 · Cited by 609 · see citing works

Alpha-linolenic acid and its conversion to longer chain n−3 fatty acids: Benefits for human health and a role in maintaining tissue n−3 fatty acid levels

Barceló‐Coblijn, G., & Murphy, E. J. (2009) · Progress in Lipid Research · doi:10.1016/j.plipres.2009.07.002 · Cited by 605 · see citing works

Inflammation and atherosclerosis: role of C-Reactive protein in risk assessment

Libby, P., & Ridker, P. M. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.02.006 · Cited by 596 · see citing works

Inflammatory/Antiinflammatory Properties of High-Density Lipoprotein Distinguish Patients From Control Subjects Better Than High-Density Lipoprotein Cholesterol Levels and Are Favorably Affected by Simvastatin Treatment

Ansell, B. J., Navab, M., Hama, S. Y., Kamranpour, N., Fonarow, G. C., Hough, G., Rahmani, S., Mottahedeh, R., Dave, R., Reddy, S. T., et al. (2003) · Circulation · doi:10.1161/01.cir.0000103624.14436.4b · Cited by 588 · see citing works

VITAMIN E, OXIDATIVE STRESS, AND INFLAMMATION

Singh, U. P., Devaraj, S., & Jialal, I. (2005) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.24.012003.132446 · Cited by 574 · see citing works

C-Reactive Protein: Risk Marker or Mediator in Atherothrombosis?

Jialal, I., Devaraj, S., & Venugopal, S. K. (2004) · Hypertension · doi:10.1161/01.hyp.0000130484.20501.df · Cited by 569 · see citing works

Endothelial Function Testing as a Biomarker of Vascular Disease

Verma, S., Buchanan, M. R., & Anderson, T. J. (2003) · Circulation · doi:10.1161/01.cir.0000089191.72957.ed · Cited by 565 · see citing works

Habitual Dietary Intake of n-3 and n-6 Fatty Acids in Relation to Inflammatory Markers Among US Men and Women

Pischon, T., Hankinson, S. E., Hotamisligil, G. S., Rifai, N., Willett, W. C., & Rimm, E. B. (2003) · Circulation · doi:10.1161/01.cir.0000079224.46084.c2 · Cited by 560 · see citing works

Effects of exercise and diet on chronic disease

Roberts, C. K., & Barnard, R. J. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00852.2004 · Cited by 556 · see citing works

Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids

Adkins, Y. C., & Kelley, D. S. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.12.004 · Cited by 557 · see citing works

C-reactive Protein as a Predictor of Prognosis in Chronic Obstructive Pulmonary Disease

Dahl, M., Vestbo, J., Lange, P., Bojesen, S. E., Tybjærg‐Hansen, A., & Nordestgaard, B. G. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200605-713oc · Cited by 544 · see citing works

C-Reactive Protein and the Risk of Incident Colorectal Cancer

Erlinger, T. P. (2004) · JAMA · doi:10.1001/jama.291.5.585 · Cited by 531 · see citing works

Histopathologic Characteristics of Atherosclerotic Coronary Disease and Implications of the Findings for the Invasive and Noninvasive Detection of Vulnerable Plaques

Narula, J., Nakano, M., Virmani, R., Kolodgie, F. D., Petersen, R., Newcomb, R. L., Malik, S., Fuster, V., & Finn, A. V. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.10.054 · Cited by 528 · see citing works

C-Reactive Protein Attenuates Endothelial Progenitor Cell Survival, Differentiation, and Function

Verma, S., Kuliszewski, M. A., Li, S.-H., Szmitko, P. E., Zucco, L., Wang, C., Badiwala, M. V., Mickle, D. A. G., Weisel, R. D., Fedak, P. W. M., et al. (2004) · Circulation · doi:10.1161/01.cir.0000127577.63323.24 · Cited by 523 · see citing works

Clinical Usefulness of Very High and Very Low Levels of C-Reactive Protein Across the Full Range of Framingham Risk Scores

Ridker, P. M., & Cook, N. R. (2004) · Circulation · doi:10.1161/01.cir.0000125690.80303.a8 · Cited by 511 · see citing works

Elevated C-Reactive Protein Levels, Psychological Distress, and Depression in 73 131 Individuals

Wium-Andersen, M. K., Ørsted, D. D., Nielsen, S. F., & Nordestgaard, B. G. (2013) · JAMA Psychiatry · doi:10.1001/2013.jamapsychiatry.102 · Cited by 489 · see citing works

Inflammatory processes in cardiovascular disease: a route to targeted therapies

Ruparelia, N., Chai, J. T., Fisher, E. A., & Choudhury, R. P. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.185 · Cited by 477 · see citing works

High-sensitivity C-reactive protein

Bassuk, S. S., Rifai, N., & Ridker, P. M. (2004) · Current Problems in Cardiology · doi:10.1016/s0146-2806(04)00074-x · Cited by 483 · see citing works

Obstructive Sleep Apnea

Caples, S. M., Gami, A. S., & Somers, V. K. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-3-200502010-00010 · Cited by 462 · see citing works

Gut Microbiota and Inflammation

Håkansson, Å., & Molin, G. (2011) · Nutrients · doi:10.3390/nu3060637 · Cited by 454 · see citing works

Prevalence and sociodemographic correlates of antinuclear antibodies in the United States

Satoh, M., Chan, E. K. L., Ho, L. A., Rose, K. M., Parks, C. G., Cohn, R. D., Jusko, T. A., Walker, N. J., Germolec, D. R., Whitt, I. Z., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34380 · Cited by 452 · see citing works

Inflammation Effects on Motivation and Motor Activity: Role of Dopamine

Felger, J. C., & Treadway, M. T. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.143 · Cited by 453 · see citing works

What does plasma CRP tell us about peripheral and central inflammation in depression?

Felger, J. C., Haroon, E., Patel, T. A., Goldsmith, D. R., Wommack, E. C., Woolwine, B. J., Le, N.-A., Feinberg, R., Tansey, M. G., & Miller, A. H. (2020) · Molecular Psychiatry · doi:10.1038/s41380-018-0096-3 · Cited by 448 · see citing works

C-Reactive Protein: A Simple Test to Help Predict Risk of Heart Attack and Stroke

Ridker, P. M. (2003) · Circulation · doi:10.1161/01.cir.0000093381.57779.67 · Cited by 448 · see citing works

Exercise and Physical Activity: Clinical Outcomes and Applications

Kokkinos, P., & Myers, J. (2010) · Circulation · doi:10.1161/circulationaha.110.948349 · Cited by 444 · see citing works

C-Reactive Protein Modulates Risk Prediction Based on the Framingham Score

Köenig, W., Löwel, H., Baumert, J. J., & Meisinger, C. (2004) · Circulation · doi:10.1161/01.cir.0000120707.98922.e3 · Cited by 440 · see citing works

Raised CRP levels mark metabolic and functional impairment in advanced COPD

Broekhuizen, R. (2005) · Thorax · doi:10.1136/thx.2005.041996 · Cited by 441 · see citing works

The Cardiovascular Disease Continuum Validated: Clinical Evidence of Improved Patient Outcomes

Dzau, V. J., Antman, E. M., Black, H. R., Hayes, D. L., Manson, J. E., Plutzky, J., Popma, J. J., & Stevenson, W. G. (2006) · Circulation · doi:10.1161/circulationaha.106.655688 · Cited by 440 · see citing works

C-reactive protein in patients with COPD, control smokers and non-smokers

Pinto-Plata, V. (2005) · Thorax · doi:10.1136/thx.2005.042200 · Cited by 431 · see citing works

Imaging the Role of Inflammation in Mood and Anxiety-related Disorders

Felger, J. C. (2017) · Current Neuropharmacology · doi:10.2174/1570159x15666171123201142 · Cited by 432 · see citing works

A wellness study of 108 individuals using personal, dense, dynamic data clouds

Price, N. D., Magis, A. T., Earls, J. C., Glusman, G., Levy, R., Lausted, C., McDonald, D. T., Kusebauch, U., Moss, C. L., Zhou, Y., et al. (2017) · Nature Biotechnology · doi:10.1038/nbt.3870 · Cited by 427 · see citing works

Established and Emerging Plasma Biomarkers in the Prediction of First Atherothrombotic Events

Ridker, P. M., Brown, N. J., Vaughan, D. E., Harrison, D. G., & Mehta, J. L. (2004) · Circulation · doi:10.1161/01.cir.0000133444.17867.56 · Cited by 418 · see citing works

Rosuvastatin in the Primary Prevention of Cardiovascular Disease Among Patients With Low Levels of Low-Density Lipoprotein Cholesterol and Elevated High-Sensitivity C-Reactive Protein

Ridker, P. M. (2003) · Circulation · doi:10.1161/01.cir.0000100688.17280.e6 · Cited by 423 · see citing works

Antiinflammatory Effects of Angiotensin II Subtype 1 Receptor Blockade in Hypertensive Patients With Microinflammation

Fliser, D., Buchholz, K., & Haller, H. G. (2004) · Circulation · doi:10.1161/01.cir.0000140265.21608.8e · Cited by 405 · see citing works

Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysis

Kuo, H., Yen, C., Chang, C., Kuo, C.-K., Chen, J.-H., & Sorond, F. A. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70099-5 · Cited by 400 · see citing works

The Clinical Significance and Potential Role of C-Reactive Protein in Chronic Inflammatory and Neurodegenerative Diseases

Luan, Y., & Yao, Y.-M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01302 · Cited by 395 · see citing works

Nonalcoholic Fatty Liver Disease Is Associated With Carotid Atherosclerosis

Brea, Á., Mosquera, D., Martin‐Solana, E., Arizti, A., Cordero, J. L., & Ros, E. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000160613.57985.18 · Cited by 386 · see citing works

Systemic low-grade inflammation is related to both circulating and adipose tissue TNFα, leptin and IL-6 levels in obese women

Maachi, M., Piéroni, L., Bruckert, É., Jardel, C., Fellahi, S., Hainque, B., Capeau, J., & Jp, B. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802718 · Cited by 379 · see citing works

Association Between C-Reactive Protein and Age-Related Macular Degeneration

Keenan, T. D. L., & Chew, E. Y. (2017) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2017.2210 · Cited by 378 · see citing works

Association between C-reactive protein and age-related macular degeneration

Seddon, J. M. (2004) · JAMA · doi:10.1001/jama.291.6.704 · Cited by 376 · see citing works

Inflammatory Markers for Arterial Stiffness in Cardiovascular Diseases

Mozos, I. M., Malainer, C., Horbańczuk, J. O., Gug, C., Stoian, D. L., Luca, C. T., & Atanasov, A. G. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01058 · Cited by 383 · see citing works

The metabolic syndrome: time for a critical appraisal

Kahn, R., Buse, J. B., Ferrannini, E., & Stern, M. P. (2005) · Diabetologia · doi:10.1007/s00125-005-1876-2 · Cited by 373 · see citing works

Erratum: Inflammatory processes in cardiovascular disease: a route to targeted therapies

Ruparelia, N., Chai, J. T., Fisher, E. A. A., & Choudhury, R. P. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.33 · Cited by 364 · see citing works

Guidelines for the management of arterial hypertension

van de Borne, P. (2014) · Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) · doi:10.2143/ac.69.1.3011345 · Cited by 348 · see citing works

Effects of Fluticasone on Systemic Markers of Inflammation in Chronic Obstructive Pulmonary Disease

Sin, D. D., Lacy, P., York, E. L., & Man, S. F. P. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200404-543oc · Cited by 346 · see citing works

Cytokines and Glucocorticoid Receptor Signaling

Pace, T. W. W., & Miller, A. H. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04984.x · Cited by 339 · see citing works

The anti-inflammatory effects of exercise training in patients with type 2 diabetes mellitus

Kadoglou, N. P. E., Iliadis, F., Angelopoulou, N., Perrea, D., Ampatzidis, G., Liapis, C. D., & Alevizos, M. (2007) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e3282efaf50 · Cited by 337 · see citing works

C-Reactive Protein and Other Emerging Blood Biomarkers to Optimize Risk Stratification of Vulnerable Patients

Tsimikas, S., Willerson, J. T., & Ridker, P. M. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.10.066 · Cited by 335 · see citing works

Increased C-Reactive Protein Levels in the Polycystic Ovary Syndrome: A Marker of Cardiovascular Disease

Boulman, N., Levy, Y., Leiba, R., Shachar, S. S., Linn, R., Zinder, O., & Blumenfeld, Z. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031096 · Cited by 332 · see citing works

Interleukin-18 and the Risk of Coronary Heart Disease in European Men

Blankenberg, S., Luc, G., Ducimetière, P., Arveiler, D., Ferrières, J., Amouyel, P., Evans, A., Cambien, F., & Tiret, L. (2003) · Circulation · doi:10.1161/01.cir.0000099509.76044.a2 · Cited by 327 · see citing works

Oxidative stress and dysregulation of NAD(P)H oxidase and antioxidant enzymes in diet-induced metabolic syndrome

Roberts, C. K., Barnard, R. J., Sindhu, R. K., Jurczak, M., Ehdaie, A., & Vaziri, N. D. (2006) · Metabolism · doi:10.1016/j.metabol.2006.02.022 · Cited by 322 · see citing works

The Role of Peripheral Inflammatory Markers in Dementia and Alzheimer's Disease: A Meta-Analysis

Koyama, A. K., O'Brien, J., Weuve, J., Blacker, D., Metti, A. L., & Yaffe, K. S. (2012) · The Journals of Gerontology Series A · doi:10.1093/gerona/gls187 · Cited by 323 · see citing works

Obesity is the major determinant of elevated C-reactive protein in subjects with the metabolic syndrome

Aronson, D., Bartha, P., Zinder, O., Kerner, A., Markiewicz, W., Avizohar, O., Brook, G. J., & Levy, Y. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802609 · Cited by 310 · see citing works

Promising Health Benefits of the Strawberry: A Focus on Clinical Studies

Afrin, S., Gasparrini, M., Forbes-Hernández, T. Y., Reboredo‐Rodríguez, P., Mezzetti, B., Varela‐López, A., Giampieri, F., & Battino, M. A. (2016) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.6b00857 · Cited by 309 · see citing works

The role of low-grade inflammation in the polycystic ovary syndrome

Repaci, A., Gambineri, A., & Pasquali, R. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.08.002 · Cited by 300 · see citing works

An early and sustained peripheral inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosis

Emsley, H. C. A. (2003) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(03)00134-6 · Cited by 301 · see citing works

Biomarkers in acute myocardial infarction

Chan, D., & Ng, L. L. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-34 · Cited by 297 · see citing works

Plaque rupture and intact fibrous cap assessed by optical coherence tomography portend different outcomes in patients with acute coronary syndrome

Niccoli, G., Montone, R. A., Vito, L. D., Gramegna, M., Refaat, H., Scalone, G., Leone, A. M., Trani, C., Burzotta, F., Porto, I., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv029 · Cited by 292 · see citing works

Evaluation of C-Reactive Protein Measurement for Assessing the Risk and Prognosis in Ischemic Stroke

Napoli, M. D., Schwaninger, M., Cappelli, R., Ceccarelli, E., Gianfilippo, G. D., Donati, C., Emsley, H. C. A., Forconi, S., Hopkins, S. J., Masotti, L., et al. (2005) · Stroke · doi:10.1161/01.str.0000165929.78756.ed · Cited by 288 · see citing works

High-sensitivity C-reactive protein, inflammation, and cardiovascular risk: From concept to clinical practice to clinical benefit

Ridker, P. M. (2004) · American Heart Journal · doi:10.1016/j.ahj.2004.04.028 · Cited by 290 · see citing works

Anti-inflammatory effect of purified dietary anthocyanin in adults with hypercholesterolemia: A randomized controlled trial

Zhu, Y., Ling, W., Guo, H., Song, F., Ye, Q., Zou, T., Li, D., Zhang, Y., Li, G., Xiao, Y., et al. (2012) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2012.06.005 · Cited by 289 · see citing works

Complications and challenges associated with polycystic ovary syndrome: current perspectives

Palomba, S., Santagni, S., Falbo, A., & La Sala, G. B. (2015) · International Journal of Women's Health · doi:10.2147/ijwh.s70314 · Cited by 287 · see citing works

Physical Activity, Health Benefits, and Mortality Risk

Kokkinos, P. F. (2012) · ISRN Cardiology · doi:10.5402/2012/718789 · Cited by 294 · see citing works

Fruit Polyphenols: A Review of Anti-inflammatory Effects in Humans

Joseph, S. V., Edirisinghe, I., & Burton‐Freeman, B. M. (2015) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2013.767221 · Cited by 282 · see citing works

Adipokines in obesity

Leal, V. D. O., & Mafra, D. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.02.003 · Cited by 275 · see citing works

Narrative Review: Assessment of C-Reactive Protein in Risk Prediction for Cardiovascular Disease

Lloyd‐Jones, D. M., Liu, K., Tian, L., & Greenland, P. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-1-200607040-00129 · Cited by 274 · see citing works

C‐Reactive Protein (CRP)‐Lowering Agents

Prasad, K. (2006) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2006.00033.x · Cited by 271 · see citing works

Obstructive Sleep Apnea

Patel, S. R. (2019) · Annals of Internal Medicine · doi:10.7326/aitc201912030 · Cited by 269 · see citing works

Association of ozone exposure with cardiorespiratory pathophysiologic mechanisms in healthy adults

Day, D. B., Xiang, J., Mo, J., Li, F., Chung, M., Gong, J., Weschler, C. J., Ohman-Strickland, P. A., Sundell, J., Weng, W., et al. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2017.2842 · Cited by 264 · see citing works

Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation

Ridker, P. M. (2015)

[The clinical application of C-reactive protein in prognosis and prevention of cardiovascular disease].

Feng, R.-F. (2003) · PubMed

C-Reactive Protein in the Prediction of Cardiovascular Disease

Horowitz, G., & Beckwith, B. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008173430715 · Cited by 19 · see citing works

C-Reactive Protein and Cardiovascular Disease

Devaraj, B. (2007) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.1.244 · Cited by 1 · see citing works

C-Reactive Protein Screening for Cardiovascular Disease

Wiesbauer, F., & Miles, J. S. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.2.242-a · Cited by 2 · see citing works